Skip to main content
CHALF logo

Chalice Brands Ltd (CHALF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 209| 52-wk range: $0.000001 – $0.0001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Chalice Brands Ltd (CHALF) trades at $0.0001. Chalice Brands Ltd. operates in the cannabis industry, focusing on retail, production, and distribution of cannabis products in Oregon. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
Chalice Brands Ltd. operates in the cannabis industry, focusing on retail, production, and distribution of cannabis products in Oregon. The company manages a network of dispensaries and offers a variety of branded cannabis products.

Analyst Coverage for CHALF: CHALF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the CHALF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Chalice Brands Ltd (CHALF) Healthcare & Pipeline Overview

Employees98
HeadquartersPortland, United States

Chalice Brands Ltd. is a vertically integrated cannabis company based in Oregon, operating a network of retail dispensaries and producing a range of branded cannabis products. With a focus on the Oregon market, Chalice Brands competes in the specialty and generic drug manufacturing sector, facing challenges and opportunities in a rapidly evolving regulatory landscape.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for CHALF?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Chalice Brands operates in the evolving cannabis market, presenting both opportunities and risks for investors. The company's vertically integrated business model, encompassing retail, production, and distribution, provides a degree of control over its supply chain and product quality. However, the company's negative profit margin of -22.2% and negative ROE of -57.6% indicate significant challenges in achieving profitability. The company's debt-to-equity ratio of 68.87 suggests a reliance on debt financing, which could pose risks in a high-interest rate environment. Growth catalysts for Chalice Brands include expansion within the Oregon market and potential future expansion into other states as regulations evolve. The company's diverse product portfolio and established retail network provide a foundation for growth. However, investors should carefully consider the risks associated with the cannabis industry, including regulatory uncertainty, competition, and potential changes in consumer preferences. The company's high beta of 9.37 indicates significant volatility, making it a higher-risk investment.

Based on FMP financials and quantitative analysis

CHALF Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Chalice Brands operates sixteen retail dispensaries in Oregon under various banners, providing a strong retail presence in the state.

  • The company's gross margin of 41.9% indicates a reasonable level of profitability in its core operations.
  • Chalice Brands offers a diverse product portfolio, including vaporizer cartridges, edibles, and oil products under multiple brand names.
  • The company rebranded from Golden Leaf Holdings Ltd. in May 2021, signaling a strategic shift in its business focus.
  • Chalice Brands' debt-to-equity ratio of 68.87 indicates a moderate level of financial leverage.

Who Are CHALF's Competitors?

CHALF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AKAN Akanda Corp. $1.91 -3.54% —
APUS Apimeds Pharmaceuticals US, Inc. $4.59 +42.55% $7.59M —
BFRI Biofrontera Inc. $0.89 -12.23% $11.4M —
COSM COSM $0.35 -9.03% $20.7M —
QNTM Quantum BioPharma Ltd. $3.27 -4.94% $20.9M —
AYTU Aytu BioPharma, Inc. $2.04 -1.45% $21.9M —
TXMD TherapeuticsMD, Inc. $2.01 -1.95% $24.0M —
CPHI CPHI $0.65 -0.61% $27.0M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CHALF's Key Strengths?

Vertically integrated operations

  • Established retail network in Oregon
  • Diverse product portfolio
  • Strong brand recognition in the Oregon market

What Are CHALF's Weaknesses?

Negative profit margin

  • Negative return on equity
  • Limited geographic presence (Oregon only)
  • High beta indicating significant volatility

What Are the Key Risks for CHALF?

Financial-distress signal — its Altman Z-Score of -4.67 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Regulatory uncertainty in the cannabis industry could negatively impact Chalice Brands' operations.
  • Intense competition from other cannabis companies could erode Chalice Brands' market share.
  • Changes in consumer preferences could reduce demand for Chalice Brands' products.
  • Economic downturn could reduce consumer spending on cannabis products.
  • The company's negative profit margin and high debt-to-equity ratio pose financial risks.

What Are CHALF's Competitive Advantages?

  • Vertically integrated operations provide control over supply chain and product quality.
  • Established retail network in Oregon provides a strong distribution channel.
  • Proprietary brands and product formulations differentiate the company's offerings.
  • Local market expertise and relationships in the Oregon cannabis industry.

What Does CHALF Do?

Chalice Brands Ltd., formerly known as Golden Leaf Holdings Ltd., underwent a rebranding in May 2021 to reflect its evolving business strategy in the cannabis industry. Headquartered in Portland, Oregon, the company is involved in the retail, production, processing, wholesale, and distribution of cannabis products. Chalice Brands operates sixteen retail dispensaries across Oregon, under the banners of Chalice Farms (six locations), Homegrown Oregon (five locations), Cannabliss and Co (four locations), and Left Coast Connections (one location). These dispensaries serve as key distribution points for the company's diverse product portfolio. Chalice Brands offers a range of branded cannabis products, including Private Stash distillate vaporizer cartridges and single-serve fruit chew blasts under the Golden and Chalice brands. The company also produces ethanol extract products under the RXO brand name and live resin and distillate vaporizer cartridges under the Elysium Fields brand. Additionally, Chalice Brands manufactures and sells oil products under the Chalice, Golden, Private Stash, Elysium Fields, and Jackpot brand names. This vertically integrated approach allows Chalice Brands to control its supply chain and maintain product quality from cultivation to retail sale. The company's focus on the Oregon market positions it to capitalize on the state's established cannabis industry, while also navigating the regulatory complexities and competitive pressures inherent in the sector.

What Products and Services Does CHALF Offer?

  • Operates a network of retail cannabis dispensaries in Oregon.
  • Produces and processes cannabis products, including vaporizer cartridges and edibles.
  • Engages in wholesale distribution of cannabis products.
  • Manufactures oil products under various brand names.
  • Offers a range of cannabis strains and product formulations.
  • Manages multiple dispensary brands, including Chalice Farms and Homegrown Oregon.

How Does CHALF Make Money?

  • Vertically integrated model encompassing retail, production, and distribution.
  • Generates revenue through retail sales at its dispensaries.
  • Wholesale distribution to other retailers.
  • Manufacturing and sale of branded cannabis products.

What Industry Does CHALF Operate In?

Chalice Brands operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization, growing consumer demand, and intense competition. The industry is subject to complex and changing regulations at both the state and federal levels. Companies like Chalice Brands face the challenge of navigating these regulations while also competing with other cannabis producers and retailers. The market is seeing growth as more states legalize cannabis for medical and recreational use. Chalice Brands is positioned to capitalize on this growth within the Oregon market, but must also adapt to the changing competitive landscape and regulatory environment.

Who Are CHALF's Key Customers?

  • Adult recreational cannabis users in Oregon.
  • Medical cannabis patients with qualifying conditions.
  • Wholesale customers, including other cannabis retailers.
Model self-rating on this text: 66% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Chalice Brands Ltd operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Portland, US. The company is led by CEO Jeffrey Yapp. CHALF has traded publicly since 2016.

F-Score 3/9

Financial Health

Chalice Brands Ltd's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -4.67 places it in the distress zone, a signal of elevated financial risk.

CHALF Financials

Fundamental Snapshot

Current Ratio
0.5
EV/EBITDA (TTM)
0.8

Based on FMP financials and quantitative analysis

CHALF Latest News

No recent news available for CHALF.

CHALF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CHALF.

Price Targets

Wall Street price target analysis for CHALF.

CHALF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CHALF; grades run from A+ (80-100) to F (below 30).

CHALF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Chalice Brands Ltd. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and greater price volatility. This tier often includes companies that are distressed, early-stage, or have chosen not to meet the requirements for higher tiers.

  • OTC Tier: OTC Other
Liquidity: Trading volume for CHALF is likely to be low, potentially leading to wide bid-ask spreads and difficulty in executing large trades without significantly impacting the price. The limited liquidity can increase the risk of price volatility and make it challenging for investors to enter or exit positions quickly. Investors should be aware of these liquidity constraints before investing in CHALF.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in CHALF.
  • Low trading volume can lead to price volatility and difficulty in executing trades.
  • The OTC Other tier indicates a higher risk profile compared to companies listed on major exchanges.
  • Regulatory uncertainty in the cannabis industry adds to the risk of investing in CHALF.
  • Potential for delisting or suspension from the OTC market.
Due Diligence Checklist:
  • Verify the company's financial statements and disclosures.
  • Assess the company's management team and their experience.
  • Research the company's business model and competitive landscape.
  • Evaluate the company's regulatory compliance and risk management practices.
  • Monitor the company's trading volume and price volatility.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • The company operates a network of retail dispensaries in Oregon.
  • Chalice Brands has a history of operating in the cannabis industry.
  • The company has a diverse product portfolio and established brands.
  • Chalice Brands is based in Portland, Oregon.

CHALF Healthcare Stock FAQ

What does Chalice Brands Ltd. do?

Chalice Brands Ltd. is a vertically integrated cannabis company based in Oregon. It cultivates, processes, and distributes cannabis products through its network of retail dispensaries.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data may be limited or unaudited due to the company's OTC listing.
  • Analyst coverage may be limited or non-existent.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis